NPIL–Reckitt JV under strain - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NPIL–Reckitt JV under strain

Mar 27, 2000

Reckitt Benckiser, the $ 3.1 bn parent of Reckitt & Colman (R & C) India is reviewing the company’s joint venture (JV) with Nicholas Piramal (NPIL). R & C India had transferred two of its over the counter pharmaceutical brands Dettol and Dispirin to the joint venture in which it held 20% while 40% each was held by its parent and NPIL respectively.

The transfer of the brands had hit the valuation of the listed company since the transfers were made without any consideration apart from giving R & C a 20% stake in the JV. Besides, it was also announced at the time of setting up of the venture that henceforth the pharmaceutical products of the parent would be introduced through the JV and not through R & C India.

The joint venture had a turnover of Rs 2.12 bn in the first nine months of FY 2000, a 9% growth over the previous year. This in fact is slightly over the overall formulations growth of 7% shown by the pharmaceutical industry. Companies such as Glaxo India that have a very high percentage of prescription brands have also grown by 9%. It is quite possible that had the brand remained with the listed company it would have grown equally if not more.

However, the impact of the reported review on the stocks of both R & C and NPIL is still not clear since an announcement on the future of the brands is still awaited. If the joint venture splits and the brands return to the R & C fold it would be a definite positive for the stock. (R & C ‘s parent had earlier requested the FIPB for setting up a 100% subsidiary which was rejected.)

NPIL has built a network of relationships with more than half a dozen alliances and joint ventures currently in operation. The importance of continuity in these relationships cannot be overstated. If for whatsoever reason relationships turn sour, it could damage NPIL’s value in the future.


Equitymaster requests your view! Post a comment on "NPIL–Reckitt JV under strain". Click here!

  

More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why am I Recommending Caution? (Fast Profits Daily)

Sep 9, 2020

This is why I have changed my short-term view on the market.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

RECKITT BENCKISER SHARE PRICE


Mar 7, 2019 10:55 AM

TRACK RECKITT BENCKISER

  • Track your investment in RECKITT BENCKISER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS